Search

everythinglearnresearchcommunity

for

Search:↓

Taxane chemotherapy can cause permanent hair loss by damaging hair follicles and altering their DNA.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Inhibiting ALOX12 can help hair cuticle maturation by increasing S100A3 citrullination.

Key proteins and potential drugs for treating alopecia areata were identified.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Nicotinic acid reduces excessive oil production in skin cells by activating a specific receptor, which could help treat acne.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Baricitinib shows promise for treating alopecia areata with mild side effects.

A new compound shows promise as a topical treatment for hair loss.

Farudodstat may help prevent hair loss in alopecia areata by stopping immune attacks on hair follicles.

Cyproterone acetate works similarly to other treatments for hirsutism, but more research is needed.

Upadacitinib may effectively treat resistant lichen planopilaris.

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Cyclosporine A may help treat hair loss by blocking a protein that inhibits hair growth.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

New compounds show promise as nonsteroidal treatments for hair loss.